Eloxx Pharmaceuticals ELOX
NASDAQ ELOX
$13.12 -0.08 (-0.61%)
At close: Oct 22, 2026 · 4:00 PM EDT

Eloxx Pharmaceuticals (ELOX) EBITDA Margin (2011 - 2014)

Updated

Eloxx Pharmaceuticals (ELOX) recorded EBITDA Margin of -38.26% in FY2024.

Analysis

Eloxx Pharmaceuticals (ELOX) EBITDA Margin (2011 - 2014) Analysis & Trends

Starting with FY2010, Eloxx Pharmaceuticals' EBITDA Margin history includes 5 years.

  • The FY2024 figure is the highest annual EBITDA Margin in data going back to FY2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 32.68%
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 49.01%
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 6.02%
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 33.11%
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 46.01%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -124.26%
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 39.16%
10 Eloxx Pharmaceuticals 89.89 Mn 16.21 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 -1,073,265.83%
Sep 30, 2014 -287,139.83%
Jun 30, 2014 -131,701.07%
Dec 31, 2011 -697.24%
API Access

Eloxx Pharmaceuticals EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ELOX&period=max&api_key=YOUR_API_KEY